Literature DB >> 17653290

The usefulness of large studies in psychopharmacology: understanding their strong points and their drawbacks.

Pierre Blier.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17653290      PMCID： PMC1911192     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  20 in total

1.  Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

Authors:  Patrick J McGrath; Jonathan W Stewart; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Michael E Thase; Lori Davis; Melanie M Biggs; Kathy Shores-Wilson; James F Luther; George Niederehe; Diane Warden; A John Rush
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

2.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

3.  Emergent suicidality in a clinical psychotherapy trial for adolescent depression.

Authors:  Jeffrey A Bridge; Rémy P Barbe; Boris Birmaher; David J Kolko; David A Brent
Journal:  Am J Psychiatry       Date:  2005-11       Impact factor: 18.112

4.  Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison.

Authors:  M F Poirier; P Boyer
Journal:  Br J Psychiatry       Date:  1999-07       Impact factor: 9.319

5.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

Review 6.  The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.

Authors:  Alessandro Serretti; Francesco Benedetti; Raffaella Zanardi; Enrico Smeraldi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-07       Impact factor: 5.067

7.  Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.

Authors:  R Zanardi; A Serretti; D Rossini; L Franchini; C Cusin; E Lattuada; D Dotoli; E Smeraldi
Journal:  Biol Psychiatry       Date:  2001-09-01       Impact factor: 13.382

8.  Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.

Authors:  Michael E Thase; Edward S Friedman; Melanie M Biggs; Stephen R Wisniewski; Madhukar H Trivedi; James F Luther; Maurizio Fava; Andrew A Nierenberg; Patrick J McGrath; Diane Warden; George Niederehe; Steven D Hollon; A John Rush
Journal:  Am J Psychiatry       Date:  2007-05       Impact factor: 18.112

Review 9.  Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).

Authors:  Gary S Sachs; Michael E Thase; Michael W Otto; Mark Bauer; David Miklowitz; Stephen R Wisniewski; Philip Lavori; Barry Lebowitz; Mathew Rudorfer; Ellen Frank; Andrew A Nierenberg; Maurizio Fava; Charles Bowden; Terence Ketter; Lauren Marangell; Joseph Calabrese; David Kupfer; Jerrold F Rosenbaum
Journal:  Biol Psychiatry       Date:  2003-06-01       Impact factor: 13.382

10.  Effectiveness of adjunctive antidepressant treatment for bipolar depression.

Authors:  Gary S Sachs; Andrew A Nierenberg; Joseph R Calabrese; Lauren B Marangell; Stephen R Wisniewski; Laszlo Gyulai; Edward S Friedman; Charles L Bowden; Mark D Fossey; Michael J Ostacher; Terence A Ketter; Jayendra Patel; Peter Hauser; Daniel Rapport; James M Martinez; Michael H Allen; David J Miklowitz; Michael W Otto; Ellen B Dennehy; Michael E Thase
Journal:  N Engl J Med       Date:  2007-03-28       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.